Biotech / Medical: MorphoSys AG (MOR)
Posts: 402 | Member SubjectMarks: 21 | No Bans

Add SubjectMark | Show Original Post | Show Chart | Poster Summary | Share This Board

Moderated By: michael_f_murphy -- (Not Moderated) -- Started: 1/17/2000 10:40:00 AM  Revision History

Previous 10 | Next 10 | View Recent | Post Message Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsDate
402The cost of caring for people with dementia is $157-215B a year and could doubleBocor-04/04/2013 09:19 AM
401FDA proposes to dramatically lower the bar on Alzheimer's drugs March 14,Germanecki-03/14/2013 12:10 PM
400 MorphoSys AG Reports Results for Fiscal Year 2012 March 05, 2013 / 7:00 am,Germanecki-03/14/2013 12:08 PM
399MorphoSys and Heptares Sign Alliance to Develop Antibody Therapeutics Targeting Germanecki-02/13/2013 03:41 PM
398bigcharts.marketwatch.com  Germanecki-02/08/2013 10:09 AM
397 MorphoSys Receives First Patent on Novel Antibody Platform Ylanthia in the USGermanecki-02/08/2013 10:07 AM
396 MorphoSys Completes Sale of AbD Serotec to Bio-Rad January 10, 2013 / 3:30 Germanecki-02/08/2013 10:06 AM
395 Bio-Rad to Acquire MorphoSys's Research and Diagnostic Antibody Business Germanecki-02/08/2013 10:05 AM
394 MorphoSys Strengthens Patent Position on anti-CD38 Cancer Program MOR202 DeGermanecki-02/08/2013 10:05 AM
393 MorphoSys and Lanthio Pharma Sign Technology Alliance on New Class of TherapeGermanecki-11/29/2012 09:25 AM
392 MorphoSys Reports Successful Phase 1 Study of MOR103 Using a Subcutaneous AdmGermanecki-11/29/2012 09:24 AM
Previous 10 | Next 10 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2013 Knight Sac Media. All rights reserved.